| Name | Title | Contact Details |
|---|---|---|
Trey Kennedy |
Director, Marine Corps Growth | Profile |
Mark Donar |
Vice President, Logistics and Supply Chain Management | Profile |
Tani Moore |
Vice President of Human Resources | Profile |
April Behtash |
Vice President, Talent Management Services | Profile |
The Faulkner Organization is a family-owned automotive dealership group based in Pennsylvania, founded in 1932. With a legacy of over nine decades, it operates 31 dealerships across Central and Southeastern Pennsylvania, representing 22 vehicle brands. The company specializes in the sale and service of new and pre-owned vehicles. Their offerings include automotive sales, maintenance and repair services, financing and insurance assistance, genuine parts supply, and body shop repair services. The Faulkner Organization is committed to customer satisfaction, employee development, and maintaining high ethical standards in all business dealings.
Tru Consulting is dedicated to delivering exceptional Anaplan implementation and consulting services with a focus on delivery excellence. What sets us apart is our commitment to an agile, collaborative, and client-centric approach that empowers our clients to achieve their goals and drive measurable strategic impact. By leveraging our deep industry expertise in higher education and public sector, cutting-edge technology, and innovative methodologies, we are able to provide tailored solutions that address our clients most pressing challenges and opportunities. Our goal is not just to deliver projects on time and within budget, but to become a true partner to our clients, and support them as serve their communities, institution, and constituents. Why Tru Consulting? —We have over 350+ years of collective experience working in the higher education and public sector industries. — We bring proprietary modeling frameworks and tried and true approaches tailored to education and public sector connected planning. — We have a proven track record and are 100% referenceable across our 60+ clients. To learn more, visit tru.consulting
demandDrive is the industry leader in sales development and demand generation. We provide clients with a full-service sales development function as well as data & demand generation programs to help them optimize their sales & marketing processes and increase revenue growth. demandDrive provides a dedicated team of Sales Development Reps and combines best practices in sales development and demand generation with industry-leading sales enablement tools to uncover and qualify new sales opportunities. demandDrive has become a pioneer in lead Generation, specializing in developing and executing custom sales / marketing programs for clients in the technology space. Services include, but are not limited to: - Integrated Inbound & Outbound Lead Generation - Startup Sales Acceleration - Data Services - Sales & Marketing Intelligence - Demand Generation Consulting demandDrive utilizes a consultative approach to kick-start lead generation and combines the flexibility of outsourcing with the expertise and continued development of a close-knit internal team. Dedicated Sales Development Reps are seasoned through an intensive dD Certification Program and work closely with clients sales and marketing teams to understand their product. This attention to detail allows for high volume, high quality and actionable sales opportunities. demandDrive has collected top honors such as being named to the Inc. 5000 list of fastest growing private companies in the US and being deemed one of the top 20 companies in the country for work-life balance (per Glassdoor).
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.